Antitumor Peptides Screening Service

    MtoZ Biolabs provides Antitumor Peptides Screening Services that integrate high-throughput display technologies, cell-based efficacy assays, and LC-MS/MS characterization to discover peptide candidates with selective antitumor activity. Our solutions help clients identify, validate, and optimize antitumor peptides for oncology research and development.

    What Is Antitumor Peptide?

    Antitumor peptides are short amino acid sequences that inhibit tumor growth or viability through mechanisms such as triggering apoptosis, disrupting tumor cell membranes, blocking angiogenesis, modulating immune pathways, or interfering with oncogenic signaling. They can be derived from natural sources or designed synthetically and often exhibit favorable properties such as high target specificity, tunable structures, and lower systemic toxicity compared with many small molecule agents.

    Antitumor peptides are important because they:

    🔸Provide targeted strategies that can reduce off-target effects on healthy tissues.

    🔸Offer diverse mechanisms that may circumvent or delay drug resistance.

    🔸Allow modular sequence engineering to enhance stability, bioavailability, and tumor selectivity.

    🔸Support precision oncology by matching peptide features with tumor phenotypes and microenvironmental conditions.

    🔸Enable combination strategies with chemotherapy, radiotherapy, immunotherapy, and targeted biologics.

    Antitumor Peptides Screening Service at MtoZ Biolabs

    Antitumor peptide discovery relies on a combination of library interrogation, molecular recognition, functional testing, and sequence validation. MtoZ Biolabs delivers a purpose-built antitumor peptide discovery platform that moves efficiently from library screening to preclinical prioritization.

    💠High-Throughput Library Screening Against Oncology Targets

    Phage, yeast, bacterial, and cell surface display allow large peptide libraries to be screened for specific binding to tumor cell receptors, growth factors, extracellular matrix components, or tumor-associated antigens. Display platforms enrich clones with strong and selective interactions that are relevant to tumor biology.

    💠Functional Validation in Tumor Cell Systems

    Candidates are tested in relevant human cancer cell lines and primary cells where appropriate. Readouts include cytotoxicity, selective tumor killing versus normal cells, apoptosis induction, and inhibition of migration or invasion.

    💠Mechanistic Research

    Signaling pathway assays, caspase activation, mitochondrial membrane potential, reactive oxygen species, and angiogenesis models help define how peptides exert antitumor effects.

    💠Sequence Confirmation and Developability Profiling

    LC-MS/MS validates sequence identity and modifications. Stability is assessed in relevant matrices. Basic developability attributes such as solubility and aggregation tendency are profiled early.

    💠Computational Analysis and Structure Optimization

    Bioinformatics tools evaluate physicochemical properties, predict secondary structure, model peptide receptor interactions, and guide sequence refinement for potency and stability.

    antitumor-peptides-screening-service1

    Oliva Arguelles, B. et al. Br J Pharmacol. 2020.

     

    Figure 1. Preclinical Summary of CIGB-552 as Novel Antitumor Peptide

    Why Choose MtoZ Biolabs

    ✔️Extensive peptide library resources covering both natural and synthetic sources to support comprehensive screening.

    ✔️Fully customizable screening and analysis strategies tailored to specific project goals and targets.

    ✔️Advanced high-throughput screening platforms integrated with bioinformatics tools for accurate data processing and interpretation.

    ✔️A professional and experienced scientific team providing expert technical guidance and reliable project support.

    Applications of Antitumor Peptides Screening Service

    1. Lead Discovery for Oncology Programs

    Identify peptide candidates that target tumor antigens, receptors, or microenvironmental factors and demonstrate selective antitumor effects.

    2. Mechanism Exploration and Target Validation

    Use peptides as probes to dissect signaling pathways or confirm target relevance in specific tumor contexts.

    3. Combination Strategy Development

    Evaluate synergy with chemotherapy, targeted agents, immunotherapies, and radiation to enhance overall efficacy.

    4. Drug Resistance Research

    Screen against resistant cell lines to identify peptides that bypass or reverse known resistance mechanisms.

    5. Tumor Microenvironment Studies

    Explore peptides that modulate stromal interactions, immune infiltration, angiogenesis, or metabolic stress within tumors.

    FAQ

    Q1: What types of samples are suitable?

    We accept a wide range of sample types, including recombinant or expressed peptides, protein targets, biological fluids, tissue, and cells. For other sample types or projects with specific requirements, please contact MtoZ Biolabs in advance for tailored preparation guidance.

    Q2: How should I prepare my samples?

    1. Ensure samples are freshly prepared or snap-frozen.

    2. Avoid using detergents, reducing agents, or preservatives that may interfere with LC-MS/MS analysis.

    3. Store samples at –80 °C before shipment.

    4. Transport samples on dry ice to maintain stability during delivery.

    For more information, please refer to Sample Submission Guidelines for Proteomics.

    Q3: What is the service general workflow?

    antitumor-peptides-screening-service2

    Q4: What data formats are provided?

    1. Comprehensive result reports provided in PDF format, including experimental workflow, screening results, and interpretation.

    2. Raw and processed data files available in Excel or CSV format for convenient secondary analysis.

    3. Sequence and spectral data from LC-MS/MS or peptide identification provided in standard formats such as FASTA and mzML.

    4. Visual data outputs, including activity curves and comparison charts, delivered in high-resolution image formats such as PNG or TIFF.

    5. Additional formats can be provided upon request to meet specific analysis or publication requirements.

    Start Your Project with MtoZ Biolabs

    Contact us today to discuss your Antitumor Peptide Screening project. Our experts are ready to provide professional guidance, customized solutions, and a detailed quotation based on your research needs.

Submit Inquiry
Name *
Email Address *
Phone Number
Inquiry Project
Project Description *

 

How to order?


How to order

Submit Your Request Now ×
/assets/images/icon/icon-message.png

Submit Inquiry

/assets/images/icon/icon-return.png